Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market, Global Outlook and Forecast 2023-2028

Report ID: 1568117 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Overall Market Size
    2.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size: 2021 VS 2028
    2.2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players in Global Market
    3.2 Top Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Companies Ranked by Revenue
    3.3 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Drugs Treatment
        4.1.3 Other Treatments
    4.2 By Type - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2017-2028
        6.3.2 US Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.3.3 Canada Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2017-2028
        6.4.2 Germany Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.4.3 France Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.4.5 Italy Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.4.6 Russia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2017-2028
        6.5.2 China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.5.3 Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.5.6 India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.7.3 Israel Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
        6.7.5 UAE Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 Endoceutics
        7.1.1 Endoceutics Corporate Summary
        7.1.2 Endoceutics Business Overview
        7.1.3 Endoceutics Postmenopausal Vaginal Atrophy (PVA) Therapeutics Major Product Offerings
        7.1.4 Endoceutics Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 Endoceutics Key News
    7.2 Accord Healthcare
        7.2.1 Accord Healthcare Corporate Summary
        7.2.2 Accord Healthcare Business Overview
        7.2.3 Accord Healthcare Postmenopausal Vaginal Atrophy (PVA) Therapeutics Major Product Offerings
        7.2.4 Accord Healthcare Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Accord Healthcare Key News
    7.3 Pfizer
        7.3.1 Pfizer Corporate Summary
        7.3.2 Pfizer Business Overview
        7.3.3 Pfizer Postmenopausal Vaginal Atrophy (PVA) Therapeutics Major Product Offerings
        7.3.4 Pfizer Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 Pfizer Key News
    7.4 Novo Nordisk
        7.4.1 Novo Nordisk Corporate Summary
        7.4.2 Novo Nordisk Business Overview
        7.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Therapeutics Major Product Offerings
        7.4.4 Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Novo Nordisk Key News
    7.5 Teva Pharmaceuticals
        7.5.1 Teva Pharmaceuticals Corporate Summary
        7.5.2 Teva Pharmaceuticals Business Overview
        7.5.3 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Therapeutics Major Product Offerings
        7.5.4 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 Teva Pharmaceuticals Key News
    7.6 Shionogi & Co
        7.6.1 Shionogi & Co Corporate Summary
        7.6.2 Shionogi & Co Business Overview
        7.6.3 Shionogi & Co Postmenopausal Vaginal Atrophy (PVA) Therapeutics Major Product Offerings
        7.6.4 Shionogi & Co Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 Shionogi & Co Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Drivers in Global Market
    Table 3. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Postmenopausal Vaginal Atrophy (PVA) Therapeutics in Global Market
    Table 5. Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Type
    Table 9. List of Global Tier 1 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. Endoceutics Corporate Summary
    Table 31. Endoceutics Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Offerings
    Table 32. Endoceutics Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. Accord Healthcare Corporate Summary
    Table 34. Accord Healthcare Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Offerings
    Table 35. Accord Healthcare Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. Pfizer Corporate Summary
    Table 37. Pfizer Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Offerings
    Table 38. Pfizer Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Novo Nordisk Corporate Summary
    Table 40. Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Offerings
    Table 41. Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. Teva Pharmaceuticals Corporate Summary
    Table 43. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Offerings
    Table 44. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 45. Shionogi & Co Corporate Summary
    Table 46. Shionogi & Co Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Offerings
    Table 47. Shionogi & Co Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Segment by Type in 2021
    Figure 2. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Segment by Application in 2021
    Figure 3. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in 2021
    Figure 8. By Type - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. Endoceutics Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Accord Healthcare Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Pfizer Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Shionogi & Co Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Postmenopausal Vaginal Atrophy Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Postmenopausal Vaginal Atrophy Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Postmenopausal Vaginal Atrophy Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports